Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in rats

European Journal of Neuroscience

Volumn 24, Issue 9, 2006, Pages 2595-2600

  Carter, Lawrence P ^a,b   Koek, Wouter ^a   France, Charles P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Baclofen; Central; Operant; Peripheral; Potency

Indexed keywords

1,4 BUTANEDIOL; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; BACLOFEN; GAMMA BUTYROLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENCY; MALE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

4-BUTYROLACTONE; ANESTHETICS, INTRAVENOUS; ANIMALS; BACLOFEN; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BRAIN; BUTYLENE GLYCOLS; GABA AGONISTS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM OXYBATE;

EID: 33750927653     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05146.x     Document Type: Article

References (46)

1. Aldrete, J.A. & Barnes, D.P. (1968) 4-Hydroxybutyrate anaesthesia for cardiovascular surgery. A comparison with halothane. Anaesthesia, 23, 558-565.
2. Baker, L.E., Van Tilburg, T.J., Brandt, A.E. & Poling, A. (2005) Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats. Psychopharmacology, 181, 458-466.
3. Caldicott, D.G., Chow, F.Y., Burns, B.J., Felgate, P.D. & Byard, R.W. (2004) Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia. Med. J. Aust., 181, 310-313.
4. Carai, M.A., Colombo, G., Reali, R., Serra, S., Mocci, I., Castelli, M.P., Cignarella, G. & Gessa, G.L. (2002) Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into γ-hydroxybutyric acid. Eur. J. Pharmacol., 441, 157-163.
5. Carter, L.P., Flores, L.R., Wu, H., Chen, W., Unzeitig, A.W., Coop, A. & France, C.P. (2003) The role of GABAB receptors in the discriminative stimulus effects of γ-hydroxybutyrate in rats: time course and antagonism studies. J. Pharmacol. Exp. Ther., 305, 668-674.
6. Carter, L.P., Wu, H., Chen, W., Cruz, C.M., Lamb, R.J., Koek, W., Coop, A. & France, C.P. (2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors. J. Pharmacol. Exp. Ther., 308, 182-188.
7. Cunningham, J.T. & Johnson, A.K. (1989) Decreased norepinephrine in the ventral lamina terminalis region is associated with angiotensin II drinking response deficits following local 6-hydroxydopamine injections. Brain Res., 480, 65-71.
8. Degenhardt, L., Darke, S. & Dillon, P. (2003) The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. Addiction, 98, 199-204.
9. Deguchi, Y., Inabe, K., Tomiyasu, K., Nozawa, K., Yamada, S. & Kimura, R. (1995) Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis. Pharm. Res., 12, 1838-1844.
10. Ebenezer, I.S. & Baldwin, B.A. (1990) Effects of intracerebroventricular administration of the GABA-B receptor agonist baclofen on operant feeding in satiated pigs. Br. J. Pharmacol., 101, 559-562.
11. Eckermann, K.A., Koek, W. & France, C.P. (2004) Chronic 1,4-butandiol treatment in rats: cross tolerance to gamma-hydroxybutyrate and (+/-)-baclofen. Eur. J. Pharmacol., 484, 259-262.
12. EISohly, M.A. & Salamone, S.J. (1999) Prevalence of drugs used in cases of alleged sexual assault. J. Anal. Toxicol., 23, 141-146.
13. Erwin, V.G. & Deitrich, R.A. (1966) Brain aldehyde dehydrogenase. J. Biol. Chem., 241, 3533-3539.
14. Giarman, N.J. & Roth, R.H. (1964) Differential estimation of gamma-butyrolactone and gamma-hydroxybutyric acid in rat blood and brain. Science, 145, 583-584.
15. Guidotti, A. & Ballotti, P.L. (1970) Relationship between pharmacological effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate. Biochem. Pharmacol., 19, 883-894.
16. Kintz, P., Villain, M., Pélissier, A., Cirimele, V. & Leonetti, G. (2005) Unusually high concentrations in a fatal GHB case. J. Anal. Toxicol., 29, 582-585.
17. Kleinschmidt, S., Grundmann, U., Janneck, U., Kreienmeyer, J., Kulosa, R. & Larsen, R. (1997) Total intravenous anaesthesia using propofol, gamma-hydroxybutyrate or midazolam in combination with sufentanil for patients undergoing coronary artery bypass surgery. Eur. J. Anaesthesiol., 14, 590-599.
18. Koek, W., Flores, L.R., Carter, L.P., Lamb, R.J., Chen, W., Wu, H., Coop, A. & France, C.P. (2004) Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in pigeons: involvement of diazepam-sensitive and -insensitive GABAA receptors and of GABAB receptors. J. Pharmacol. Exp. Ther., 308, 904-911.
19. Laborit, H., Jouany, J.M., Gerard, J. & Fabiani, F. (1960) Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate. Presse. Med., 68, 1867-1869.
20. Lettieri, J. & Fung, H. (1978) Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium γ-hydroxybutyrate and γ-butyrolactone. Res. Commun. Chem. Pathol. Pharmacol., 22, 107-118.
21. Li, J., Stokes, S.A. & Woeckener, A. (1998) A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose. Ann. Emerg. Med., 31, 723-728.
22. Liebman, J.M. & Pastor, G. (1980) Antinociceptive effects of baclofen and muscimol upon intraventricular administration. Eur. J. Pharm., 61, 225-230.
23. Liechti, M.E., Kunz, I., Greminger, P., Speich, R. & Kupferschmidt, H. (2006) Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend., 81, 323-326.
24. Lora-Tamayo, C., Tena, T., Rodríguez, A., Sancho, J.R. & Molina, E. (2003) Intoxication due to 1,4-butanediol. Forensic Sci. Int., 133, 256-259.
25. Maxwell, R. & Roth, R.H. (1972) Conversion of 1,4-butanediol to - hydroxybutyric acid in rat brain and in peripheral tissue. Biochem. Pharmacol., 21, 1521-1533.
26. Palmer, R.B. (2004) Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate. Toxicol. Rev., 23, 21-31.
27. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
28. Quang, L.S., Shannon, M.W., Woolf, A.D., Desai, M.C. & Maher, T.J. (2002) Pretreatment of CD-1 mice with 4-methylpyrazole blocks toxicity from the gamma-hydroxybutyrate precursor 1,4-butanediol. Life Sci., 71, 771-778.
29. Raskin, N.H. & Sokoloff, L. (1968) Brain alcohol dehydrogenase. Science, 162, 131-132.
30. Romanelli, F., Smith, K.M. & Pomeroy, C. (2003) Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men. Top. HIV Med., 11, 25-32.
31. Roth, R.H., Delgado, J.M. & Giarman, N.J. (1966) γ- Butyrolactone and γ-hydroxybutyric acid. II. The pharmacologically active form. Int. J. Neuropharmacol., 5, 421-428.
32. Roth, R.H. & Giarman, N.J. (1965) Preliminary report on the metabolism of γ-butyrolactone and γ-hydroxybutyric acid. Biochem. Pharmacol., 14, 177-178.
33. Roth, R.H. & Giarman, N.J. (1968) Evidence that central nervous system depression by 1,4-butanediol is mediated through a metabolite, gamma-hydroxybutyrate. Biochem. Pharmacol., 17, 735-739.
34. Schwartz, R.H., Milteer, R. & Lebeau, M.A. (2000) Drug-facilitated sexual assault ('date rape'). South. Med. J., 93, 558-561.
35. Shafizadeh, M., Semnanian, S., Zarrindast, M.R. & Hashemi, B. (1997) Involvement of GABAB receptors in the antinociception induced by baclofen in the formalin test. General Pharm., 28, 611-615.
36. Simpson, J.B. & Routtenberg, A. (1972) The subfornical organ and carbachol-induced drinking. Brain Res., 45, 135-152.
37. Singh, R. & Ticku, M.K. (1987) Central cardiovascular effects of baclofen in spontaneously hypertensive rats. Life Sci., 40, 1017-1026.
38. Snead, O.C. 3rd (1991) The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology, 30, 161-167.
39. Snead, O.C. 3rd, Furner, R. & Liu, C.C. (1989) In vivo conversion of γ-aminobutyric acid and 1,4-butanediol to γ-hydroxybutyric acid in rat brain. Studies using stable isotopes. Biochem. Pharmacol., 38, 4375-4380.
40. Tallarida, R.J. (2000) Drug Synergism and Dose-Effect Data Analysis. Chapman & Hall, Boca Raton.
41. Theron, L., Jansen, K. & Skinner, A. (2003) New Zealand's first fatality linked to use of 1,4-butanediol (1,4-B, Fantasy): no evidence of coingestion or comordibity. N. Z. Med. J., 116, U650.
42. United States Environmental Protection Agency (2002) Inventory update rule.
43. United States Federal Register (2000) Schedules of controlled substances: addition of gamma-hydroxybutyric acid to Schedule I. Drug Enforcement Administration, Department of Justice. Final rule. Fed. Regist., 65, 13235-13238.
44. Vickers, M.D. (1969) Gammahydroxybutyric acid. Int. Anesthesiol. Clin., 7, 75-89.
45. Yambo, C.M., McFee, R.B., Caraccio, T.R. & McGuigan, M. (2004) The inkjet cleaner 'Hurricane' - another GhB recipe. Vet. Hum. Toxicol., 46, 329-330.
46. Zvosec, D.L., Smith, S.W., McCutcheon, J.R., Spillane, J., Hall, B.J. & Peacock, E.A. (2001) Adverse events, including death, associated with the use of 1,4-butanediol. N. Engl. J. Med., 344, 87-94.